The Truth Behind David Sinclair's Anti-Aging Claims

The Rise and Fall of Resveratrol

• 💡 David Sinclair, a Harvard professor, gained fame for claims that resveratrol, a compound in red wine, could activate the SIR1 protein and extend lifespan.
• 🚀 His early lab studies on mice seemed promising, leading to the formation of Sirtris Pharmaceuticals in 2004, built on the promise of resveratrol and its synthetic variants.
• 💰 In 2008, GlaxoSmithKline (GSK) acquired Sirtris for a staggering $720 million, believing in the potential to revolutionize medicine by slowing aging.
• 📉 However, subsequent experiments by GSK and independent labs failed to replicate Sinclair's initial results, and reanalysis in 2011 revealed that the supposed SIR1 activation was due to a fluorescent dye, not resveratrol itself.

The NMN Controversy

• 🔄 After resveratrol's downfall, Sinclair pivoted to NMN, another compound, claiming it could boost NAD+ levels and potentially slow aging, promoting it on major platforms like the Joe Rogan podcast.
• 🏢 Sinclair launched a new company, Metro Biotech, with a proprietary version of NMN and subsequently lobbied the FDA to ban over-the-counter NMN supplements, which critics argue was a move to eliminate competition.

Scientific Backlash and Ethical Concerns

• 🗣️ Former colleagues, including Professor Matt Kaeberlein and Jeffrey Flier, former dean of Harvard Medical School, publicly criticized Sinclair's ethics and scientific rigor.
• ⚠️ Critics accused Sinclair of publishing studies with questionable methods, overly optimistic interpretations, and poor controls, creating a pattern of